Under the final Medicare Physician Fee Schedule that goes into effect Jan. 1, new Part B drugs will be reimbursed at a lower rate. Part B drugs, in their first quarter of sales, have been covered based on the wholesale acquisition cost plus a 6 percent add-on. In 2019, they will receive only a 3 percent add-on.